Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
16.14
-0.98 (-5.72%)
Nov 17, 2026, 3:00 PM CST

SHA:688393 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-34.95-47.0221.2940.0642.6979.78
Depreciation & Amortization
41.2341.2340.7540.9935.6918.58
Other Amortization
10.5710.575.726.0243.34
Loss (Gain) From Sale of Assets
0.250.25-0.33-0.360.02-0.31
Asset Writedown & Restructuring Costs
13.5813.583.854.060.120.93
Loss (Gain) From Sale of Investments
-21.24-21.24-5.35-5.143.14-12.86
Provision & Write-off of Bad Debts
335.674.55.351.69
Other Operating Activities
-30.36-2.26-9.9-22.24-11.39-2.68
Change in Accounts Receivable
69.1869.18-7.45-9.29-36.17-35
Change in Inventory
-16.67-16.67-30.23-30.49-23.07-16.65
Change in Accounts Payable
4.864.86-5.41-6.17-7.0417.02
Change in Other Net Operating Assets
-7.09-7.09-6.435.83--
Operating Cash Flow
23.9940.023.5417.129.7259.61
Operating Cash Flow Growth
-37.73%1029.39%-79.31%76.21%-83.70%-34.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17.9-23.15-23.65-37.74-72.17-143.34
Sale of Property, Plant & Equipment
0.09-0.032.932.22.93
Cash Acquisitions
-7.13-7.13--1.25--31.85
Investment in Securities
52.26-62.2677.220.9-52.33-281.67
Other Investing Activities
10.817.963.512.477.377.32
Investing Cash Flow
38.12-74.5857.12-32.7-114.92-446.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.157.321.214.37
Total Debt Issued
-18.940.157.321.214.37
Short-Term Debt Repaid
--7.3-21.2-14.3-7-
Long-Term Debt Repaid
--2.06-2.14-2.51-2.67-2.53
Lease Payments
-2.06-2.06-2.14-2.51-2.67-2.53
Total Debt Repaid
5.58-9.36-23.34-16.81-9.67-2.53
Net Debt Issued (Repaid)
-13.35-9.21-16.044.394.634.47
Issuance of Common Stock
---2.18--
Common Dividends Paid
-9.53-9.53-14.51-13.47-26.61-26.33
Other Financing Activities
-21.53-8.83-4.17-0.58-7.67
Financing Cash Flow
-48.36-27.57-34.72-6.89-21.4-29.53

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.14-0.04-0.120.080.14-0.06
Net Cash Flow
13.6-62.1725.82-22.39-126.46-416.58

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6.0916.87-20.1-20.62-62.45-83.73
Free Cash Flow Growth
-72.85%-----
Free Cash Flow Margin
1.71%4.90%-4.27%-4.15%-12.31%-19.07%
Free Cash Flow Per Share
0.050.18-0.22-0.22-0.66-0.89
Levered Free Cash Flow
117.38181.68-91.53-108.95-69.45-122.56
Unlevered Free Cash Flow
117.52181.89-91.12-108.45-68.6-122.32
Free Cash Flow After Leases
4.0314.81-22.24-23.13-65.12-86.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
34.0728.1631.127.3123.1317.02
Change in Working Capital
41.9241.92-58.17-50.77-69.9-28.85